Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Bungotoxin Antigen Epitope Gene and Its Application in Gene Vaccine and Antigen Preparation

A technology of antigenic sites and vaccines, applied in the field of biomedicine

Inactive Publication Date: 2017-02-22
中国人民解放军成都军区疾病预防控制中心
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Apart from this, there are no other related reports

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Bungotoxin Antigen Epitope Gene and Its Application in Gene Vaccine and Antigen Preparation
  • Bungotoxin Antigen Epitope Gene and Its Application in Gene Vaccine and Antigen Preparation
  • Bungotoxin Antigen Epitope Gene and Its Application in Gene Vaccine and Antigen Preparation

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] (1) Acquisition of SEQ ID NO: 1

[0070] (1) Antigenic sites obtained by bioinformatics analysis

[0071] Two representative sequences extracted from the long chain of α-bungarotoxin (BGT), the A and B chains of β-BGT, and the κ-BGT class: AF056407, AF056407, AJ242012, AJ242011, Y12100, Y12101, Y12265, Y12266 (The above is the ID number in NCBIGenbank).

[0072] Using SignalP software ( http: / / www.cbs.dtu.dk / services / SignalP-2.0 / ) to analyze the signal peptide and propeptide sequences of the above 8 sequences, remove the signal peptide and propeptide sequences and retain the mature peptide sequence for analysis. The secondary structure of the amino acid sequence is predicted by the Jameson-Wolf method combined with the Gamier-Robson and Chou-Fasman method, the hydrophobicity is analyzed by the Kyte-Doolittle method, the flexibility is analyzed by the Karplus-Schulz method, and the site surface possibility is analyzed by the Emini method, Finally, the combination of...

Embodiment 2

[0099] (3) Application of SEQ ID NO: 3 in preparation of antigen by prokaryotic expression

[0100] Design of SEQ ID NO: 3

[0101] On the basis of SEQ ID NO: 1, the Not I (gtg cgg ccg c) and BamH I (gga tcc gc) restriction site sequences on SEQ ID NO: 1 were replaced with BamH I (gta gga tcc) and SalI ( taa gtc gac gta) restriction site sequence and then handed over to a professional company for whole gene synthesis.

[0102] (1) Submit SEQ ID NO: 3 to Beijing Liuhe Huada Gene Technology Co., Ltd. for synthesis. The pUC57 plasmid containing the synthetic gene and the prokaryotic expression plasmid pET-28a(+) were subjected to Sal I / BamH I double enzyme digestion, respectively, and the digestion conditions were carried out according to the instructions of the corresponding enzymes.

[0103] (2) The digested product was confirmed to be about 350 bp in size by agarose electrophoresis, and the target fragment was excised, and then recovered according to the instructions of the ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a bungatotoxin antigen epitope gene and application of the bungatotoxin antigen epitope gene to the preparation of a gene vaccine and an antigen. Two representative sequences are extracted from each of a long chain of alpha-BGT, chains A and B of beta-BGT and kappa-BGT of a cDNA sequence of bungatotoxin, the signal peptide and propeptide parts of the sequences are removed, mature peptide parts are collected, 10 antigen sites are obtained through analysis by a bioinformatics method, and a gene sequence containing the 10 sites is manually synthesized, and is connected to an eukaryotic expression vector pIRESneo to immunize an animal as the gene vaccine to obtain an anti-bungatotoxin neutralizing antibody; the sequence can also be connected to a prokaryotic expression vector PET-28a and then transformed to expression bacterium BL21 to induce the expression of the protein, and the target protein is separated to immunize the animal as an immunogen to obtain the anti-bungatotoxin neutralizing antibody.

Description

technical field [0001] The invention relates to the preparation of a gene and its vaccine, in particular to an artificially synthesized polypeptide sequence from a plurality of antigenic epitopes in α, β and κ silvercycline toxins, a gene and its application, belonging to the field of biomedicine. [0002] technical background [0003] Venomous snakebites have long been a serious public health problem in rural areas of Asian and African countries. Snake venom toxins can be divided into three categories according to their properties: nerve poisons, blood circulation poisons, and mixed poisons. Antivenom is the most effective treatment for poisonous snake bites. However, due to the complex composition of snake venom itself, which contains dozens or even hundreds of proteins with different functions, the antivenom produced by horses immune to venom contains not only Antibodies that neutralize toxin components also contain a large number of antibodies against other non-toxin com...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/12C12N15/79C12N15/70C07K14/46C07K16/18A61K48/00A61P39/02
Inventor 郑颖范泉水崔庆华张志晓叶锋平郭平冯子良周卫国
Owner 中国人民解放军成都军区疾病预防控制中心
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com